Pig Castration Welfare: Surgical, Immunological and Breed Alternatives

Male pig castration prevents boar taint in meat but causes significant pain. Understanding alternatives guides welfare-conscious production decisions.

Key Facts

Castration is performed in 80% of European male pig production
Surgical castration without anaesthesia is still legal in the EU for piglets under 7 days
Boar taint affects approximately 5% of entire males, detectable by consumers when heated
Immunocastration (Improvac) causes temporary immune suppression of testosterone production
Entire male production avoids surgery but requires management of aggression
Breed selection can reduce boar taint incidence but does not eliminate it

Welfare Considerations

Surgical castration without anaesthesia causes acute and lasting pain. Piglets vocalise intensely, show pain behaviours, and have elevated cortisol for hours post-procedure. The EU European Declaration committed to voluntary phase-out of surgical castration without pain relief by 2018 - a deadline largely missed. Immunocastration, while requiring injections, avoids surgical trauma and is welfare-superior. The economic case for pain relief in castration is increasingly recognised by industry.

What You Can Do

Support pig producers using immunocastration or entire male production
Choose pork certified to standards banning castration without pain relief
Advocate for mandatory anaesthesia and analgesia in all pig castration procedures